Edity Therapeutics is looking to hire an Immunologist · PhD in Immunology/ vaccine/mAb discovery · Director level · Based in Israel · Industry experience - at least 5 years · Very high interpersonal skills · Excellent operational skills Please send CV to [email protected]
Edity Therapeutics
Biotechnology Research
Rehovot, Israel 1,586 followers
Using human immune cells to deliver therapeutic proteins
About us
Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.
- Website
-
www.edity-tx.com
External link for Edity Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Rehovot, Israel
- Type
- Privately Held
- Founded
- 2020
- Specialties
- gene editing, cell therapy, gene therapy, drug delivery, and cancer
Locations
-
Primary
Rehovot, Israel, IL
Employees at Edity Therapeutics
Updates
-
🚀 Exciting News in the Biotech World! 🚀 We are thrilled to announce a groundbreaking strategic collaboration between Edity Therapeutics and Aurigene Pharmaceutical Services Limited, a global CRDMO, in the field of cell therapy. This partnership marks a significant milestone in advancing innovative treatments and enhancing patient care. Check out the details in the articles below: https://lnkd.in/d7y-_Dpg https://lnkd.in/dFUS_r3i https://lnkd.in/dWbqbKE4 Together, Edity Therapeutics and Aurigene are paving the way for next-generation cell therapies, combining cutting-edge technology with unparalleled expertise. Stay tuned for more updates on this exciting journey towards revolutionizing healthcare! 🌟 #Biotech #CellTherapy #Innovation #Healthcare #EdityTherapeutics #AurigenePharma #Collaboration #MedicalResearch #LifeSciences
-
🌟 Exciting News from USBIO 2024! 🌟 We are thrilled to share that Abigail Bracha, our President had the incredible opportunity to attend this year's USBIO conference. It was an amazing experience for us to connect with industry leaders, exchange ideas, and explore the latest advancements in the biotech field. One of the highlights of the conference was Abigail's meeting with the dynamic representatives from Aurigene Pharmaceutical Services Ltd. Aurigene's commitment to innovation and cutting-edge research aligns perfectly with our vision, and we are excited about the possibilities that lie ahead. Thank you to everyone who made USBIO 2024 a success. #USBIO2024 #Biotechnology #Innovation #Collaboration #Aurigene #Networking #FutureOfBiotechAbigail Bracha Aurigene Pharmaceutical Services Limited
-
🚀 Exciting News! 🚀 We are thrilled to announce that Abigail Bracha, President of Edity, will be attending the US BIO International Conference in June 2024! 🌍 At the conference, Abigail will be engaging with industry leaders, sharing insights on Edity's cutting-edge projects, and exploring new opportunities for partnership and growth. We believe that her presence at BIO will significantly contribute to the vibrant discussions and pioneering initiatives that define this influential gathering. Stay tuned for updates from the conference. Together, we are shaping the future of biotechnology! 🌟 #BIO2024 #Biotechnology #Innovation #Leadership #Edity #GlobalConference #BiotechLeadership
-
Exciting News in Biotech! 🚀 Thrilled to share the latest developments from Johnson & Johnson and Bristol Myers Squibb as they gear up to meet the growing demand for CAR-T therapies in multiple myeloma. In response to recent label expansions, both companies are ramping up their lentiviral production and CAR-T product capacities, showcasing their commitment to advancing treatment options for patients. Read more about this significant stride in biotech innovation in Anna Brown's insightful article below: https://lnkd.in/d-fBdpfT #Biotech #Innovation #CAR-T #MultipleMyeloma #Healthcare #JNJ #BristolMyersSquibb #Science #MedicalAdvancements
J&J, Bristol Myers race to amplify CAR-T manufacturing to meet label expansion in multiple myeloma
https://endpts.com
-
Purim at Edity: We had PJ day with a Cereal Breakfast Bar A Hat day with sweet sushi session And a costume day where we had a self operated escape room, lunch all together and exchange of color schemed Mishloach Manot. #edity #purim #escaperoom
-
+12
-
Thrilled to announce our recent visit to APSL in Hyderabad, marking the beginning of an inspiring collaboration journey! 🌟 At Edity Therapeutics, we are constantly seeking groundbreaking advancements in the field of therapeutics, and our visit to APSL reaffirmed our commitment to innovation and collaboration. 💡 APSL's impressive facilities and dedicated team left us energized and excited about the possibilities that lie ahead. Together, we're poised to push boundaries, explore new frontiers, and ultimately make a difference in patients' lives. 🌍 #EdityTherapeutics #APSL #Collaboration #Innovation #Biotech #Hyderabad #Therapeutics #Healthcare #Partnership
-
A heartfelt thank you to the incredible team at Aurigene for the warm welcome and enriching discussions during our recent visit to India! 🇮🇳🤝 Being immersed in Aurigene's culture of innovation and dedication to excellence has been truly inspiring. From insightful conversations to exploring new avenues of collaboration, every moment was filled with enthusiasm and possibility. We are deeply grateful for the opportunity to exchange ideas, learn from each other, and lay the groundwork for exciting projects ahead. The passion and expertise of the Aurigene team are evident in everything they do, and we are honored to be part of this journey. Here's to the beginning of a fruitful partnership that will undoubtedly drive positive change in our industry and beyond. Thank you, Aurigene, for your hospitality, friendship, and unwavering commitment to pushing boundaries and making a difference. Let's continue to innovate and thrive together! 🚀🌍 #Collaboration #Innovation #Aurigene #PartnershipSuccess #edity
-
🌟 Breakthrough Alert! 🚀 New senolytic therapy using CAR T cells targets age-related decline. 🧬 In tests, uPAR-positive senescent cells were safely eliminated. Results? Improved exercise capacity, enhanced glucose tolerance in aged and high-fat diet mice. 🐭💪 Single treatment delivers long-lasting effects. 🌈 Exciting steps toward a healthier, longer life! #SenolyticBreakthrough #AgingResearch 🌐🔬 https://lnkd.in/gCqSJP3K
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction - Nature Aging
nature.com